Hi-Tech Pharmacal Co. Inc.
http://www.hitechpharm.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Hi-Tech Pharmacal Co. Inc.
MSD Removes ‘Key Barrier’ To English Funding For Keytruda In Triple-Negative Breast Cancer
MSD has agreed to restrict the use of its Keytruda combination therapy in a manner that means that Roche’s Tecentriq combination is no longer a direct comparator.
Ukraine War Could Spur Changes In The Clinical Trial Paradigm
Decentralized trials are way to help displaced Ukrainians remain in studies and could encourage greater participation from individuals in other countries, those overseeing sites in Ukraine say.
Homegrown China Oral Antiviral Shows Early Promise
Junshi’s oral antiviral shows signs of effectiveness in treating patients with mild COVID-19 symptoms but more data are needed, caution researchers.
Scotland Okays Funding For Keytruda and Opdivo For Esophageal Cancer, Among Other Drugs
Immunotherapies for esophageal cancer from BMS and MSD are among the medicines that Scotland’s health technology appraisal body has recommended for use on the National Health system.
Company Information
- Other Names / Subsidiaries
-
- ECR Pharmaceuticals